Ledger.Open graph →
SEC Form D · filed April 15, 2019

Aro Biotherapeutics Co

Offering
$4.9M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Susan B. Dillon · Philadelphia, PAExec · DirectorMark V. Laurenzi · Philadelphia, PAExecElizabeth V. Anderson · Philadelphia, PADirectorKaryn B. O'Neil · Philadelphia, PAExec · DirectorBruce V. Peacock · Philadelphia, PADirectorSusan B. Dillon · Philadelphia, PAExec · DirectorKaryn B. O'Neil · Philadelphia, PAExec · DirectorMark V. Laurenzi · Philadelphia, PAExecElizabeth V. Anderson · Philadelphia, PADirectorBruce V. Peacock · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗